Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, agosto 28
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Astrana Health Inc
ASTH
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$38.41
-0.20
-0.52%
In chiusura: Aug 26, 5:00 PM EST
$38.50
-0.11
-0.28%
Pre-mercato: 7:00 AM EST
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Astrana Health Financials
Astrana Health (ASTH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Astrana Health Sees Q3 Sales $1.000B-$1.030B vs $1.021B Est
Astrana Health (NASDAQ:ASTH) sees Q3 sales of $1.000 billion-$1.030 billion vs $1.021 billion analyst estimate.
Benzinga Newsdesk
PRO
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.001B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.001 billion estimate.
Benzinga Newsdesk
PRO
Astrana Health Q2 EPS $0.40 Beats $0.34 Estimate, Sales $972.520M Miss $985.716M Estimate
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.34 by 17.65 percent. This is a 110.53 percent increase over earnings of $0.19 per share from
Benzinga Newsdesk
PRO
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $3.984B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $3.984 billion estimate.
Benzinga Newsdesk
PRO
Astrana Health Sees Q2 Sales $965.000M-$1.000B vs $973.326M Est
Astrana Health (NASDAQ:ASTH) sees Q2 sales of $965.000 million-$1.000 billion vs $973.326 million analyst estimate.
Benzinga Newsdesk
PRO
Astrana Health Q1 EPS $0.29 Misses $0.30 Estimate, Sales $965.100M Beat $949.206M Estimate
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.30 by 3.33 percent. This is a 107.14 percent increase over earnings of $0.14 per share from
Benzinga Newsdesk
Privacy Manager